HUMAN PAPILLOMAVIRUS
Clinical trials for HUMAN PAPILLOMAVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could two HPV shots be enough for older women? new study aims to find out
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether two doses of the HPV vaccine work as well as three doses for women aged 27 to 45. About 618 women will be randomly assigned to receive either two or three shots, and their immune response will be checked over 12 months. The goal is to see if a shorter vac…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 16:26 UTC
-
New HPV test aims to make screening easier and more accessible
Diagnosis Recruiting nowThis study is testing a new, easy-to-use HPV test that could be done right at a clinic or doctor's office, without needing a lab. Researchers want to see if this new test works as well as the standard HPV tests. The study will include 600 people with a cervix who are 21 or older.…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 01, 2026 15:56 UTC